Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-12-332133
Filing Date
2012-08-02
Accepted
2012-08-02 17:00:27
Documents
11
Period of Report
2012-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d358841d10q.htm 10-Q 970411
2 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER d358841dex311.htm EX-31.1 9987
3 CERTIFICATION OF THE ACTING CHIEF FINANCIAL OFFICER d358841dex312.htm EX-31.2 10030
4 CERTIFICATION OF THE CHIEF EXECUTIVE OFFICER d358841dex321.htm EX-32.1 4374
5 CERTIFICATION OF THE ACTING CHIEF FINANCIAL OFFICER d358841dex322.htm EX-32.2 4439
  Complete submission text file 0001193125-12-332133.txt   7555885

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT ipxl-20120630.xml EX-101.INS 1156601
7 XBRL TAXONOMY EXTENSION SCHEMA ipxl-20120630.xsd EX-101.SCH 80557
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ipxl-20120630_cal.xml EX-101.CAL 83648
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ipxl-20120630_def.xml EX-101.DEF 404873
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE ipxl-20120630_lab.xml EX-101.LAB 535453
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ipxl-20120630_pre.xml EX-101.PRE 477916
Mailing Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544
Business Address 30831 HUNTWOOD AVENUE HAYWARD CA 94544 510-240-6000
IMPAX LABORATORIES INC (Filer) CIK: 0001003642 (see all company filings)

EIN.: 650403311 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-34263 | Film No.: 121004178
SIC: 2834 Pharmaceutical Preparations